Form 4: MAIA Biotechnology Director Buys Shares
Insider Transaction (Form 4)
Ramiro Guerrero, a Director of MAIA Biotechnology, Inc., purchased 133,790 shares of common stock on August 26, 2026.
Summary
- Open-market purchase: acquired 8,931 Common Stock at $1.39 ($12,414) on August 26, 2026; holds 610,842 after (Direct).
- Open-market purchase: acquired 78,239 Common Stock at $1.39 ($108,752) on August 27, 2026; holds 689,081 after (Direct).
- Open-market purchase: acquired 46,620 Common Stock at $1.35 ($62,937) on August 28, 2026; holds 735,701 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $184,103, committing personal capital to the stock.
Insider Transactions
Ramiro Guerrero — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-26 | Open-market purchase | Common Stock | 8,931 | $1 | $12.4K | 610,842 |
| 2026-08-27 | Open-market purchase | Common Stock | 78,239 | $1 | $108.8K | 689,081 |
| 2026-08-28 | Open-market purchase | Common Stock | 46,620 | $1 | $62.9K | 735,701 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-26 | Open-market purchase (8,931 shares) |
| 2026-08-27 | Open-market purchase (78,239 shares) |
| 2026-08-28 | Open-market purchase (46,620 shares) |
Keywords
insider transaction, Form 4, MAIA, MAIA Biotechnology, Inc., bullish, Ramiro Guerrero
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.